Insider trade

Director sold ~$52K of DOCS shares in the open market

Traded Mar 3, 2026 · Filed Mar 6, 2026

Why it stands out

A board member of Doximity sold $52K of Doximity shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$52,000

Shares × reported transaction price

Timing vs results

26 days after results of Feb 5, 2026, 71 days before results of May 13, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−3.8%	−1.5%	−2.3%
30 days	−9.0%	−2.0%	−7.0%
90 days	−18.3%	+12.6%	−30.9%
180 days	+3.9%	+13.8%	−9.9%

Past results only. Not a forecast.

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2024.

7mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance7mo ago

7mo ago

Derivative exercise or conversion — not an open-market buy.